Cargando…
Optimization of Extended-Release ZL-004 Nanosuspensions for In Vivo Pharmacokinetic Study to Enhance Low Solubility and Compliance
ZL-004, a promising small molecule that increases white blood cell counts, was developed for extended-release nanosuspensions to improve low solubility and compliance of patients. In vivo pharmacokinetic studies of nanosuspensions with different particle sizes and administration volumes were conduct...
Autores principales: | Guo, Chengyue, Chen, Yanna, Zhu, Junzhe, Wang, Jiaxin, Xu, Ying, Luan, Hansen, Wang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337511/ https://www.ncbi.nlm.nih.gov/pubmed/30577480 http://dx.doi.org/10.3390/molecules24010007 |
Ejemplares similares
-
Nanosuspension: An approach to enhance solubility of drugs
por: Patel, Vishal R., et al.
Publicado: (2011) -
Preparation, characterization and pharmacokinetics of cyadox nanosuspension
por: Sattar, Adeel, et al.
Publicado: (2017) -
Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
por: Sampathi, Sunitha, et al.
Publicado: (2022) -
Preparation and Pharmacokinetic Characterization of an Anti-Virulence Compound Nanosuspensions
por: Wang, Nan, et al.
Publicado: (2021) -
Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery
por: Wang, Yonglu, et al.
Publicado: (2011)